Company Overview
| Stock Name | Kanghua Health |
|---|---|
| Stock Code | 03689 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 專注於透過多學科私立營利性綜合醫院向病人提供連續醫療服務,包括住院醫療服務、門診醫療服務及體檢,主要於廣東省東莞經營康華醫院及仁康醫院。 |
| Listing Date | 2016-11-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省東莞市東莞大道1000號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | kanghuagp.com |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 11.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | 200 shares |
| Entry Threshold | To be extracted |
| Par Value | RMB 1.0 / shares |
| Offer Period | 2016-10-27 to 2016-11-01 |
| Global Offering Shares | 84,000,000 shares |
| HK Public Offer Shares (Initial) | 8,400,000 shares (10.0%) |
| Public Offer Lots (Initial) | 42,000lots (Pool A21,000lots,Pool B21,000lots) |
| International Placing Shares (Initial) | 75,600,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 334,000,000 shares |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | To be extracted |
| Cornerstone Share | 5.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 974,400,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| Avg Daily HK Mkt Cap | HK$ 151.1M |
| Est. Threshold | HK$ 9.71B |
| Analysis Result | HK market cap below threshold, need +6330% |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 4,358,700,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 截至2015年12月31日止年度盈利約人民幣118.9百萬元 |
| Period-End Cash Balance | 人民幣95.5百萬元 |
| Listing Expenses | ~HK$ 91,600,000 |
| Listing Expenses / Funds Raised | ~9.4% |
| Total Pre-IPO Investment | To be extracted |
Financial Data
Unit:
'000
RMB
Income Statement
| Item | 2013 | 2014 | 2015 | 2016-04 |
|---|---|---|---|---|
| Revenue | 858,874 | 985,108 | 1,063,702 | 380,121 |
| Cost of sales | -669,778 | -761,424 | -824,290 | -300,020 |
| Gross profit | 189,096 | 223,684 | 239,412 | 80,101 |
| Other income and gains, net | 66,338 | 70,492 | 64,301 | 10,097 |
| Administrative expenses | -74,365 | -79,855 | -83,657 | -30,454 |
| Operating profit | 178,868 | 212,107 | 215,971 | 59,278 |
| Net finance costs | -54,126 | -76,895 | -67,153 | -5,142 |
| Profit before tax | 124,742 | 135,212 | 148,818 | 54,136 |
| Income tax expense | -15,629 | -27,445 | -29,854 | -14,414 |
| Profit for the year | 109,113 | 107,767 | 118,964 | 39,722 |
| Profit attributable to owners | 107,309 | 102,237 | 118,847 | 40,063 |
Balance Sheet
| Item | 2013 | 2014 | 2015 | 2016-04 |
|---|---|---|---|---|
| Cash and cash equivalents | 45,939 | 37,346 | 95,520 | 68,049 |
| Trade and bills receivables | 69,607 | 59,357 | 88,217 | 111,502 |
| Inventories | 35,721 | 33,672 | 38,195 | 44,339 |
| Total current assets | 671,714 | 664,816 | 775,115 | 706,826 |
| Total assets | 1,821,598 | 1,885,024 | 1,105,920 | 1,043,867 |
| Total current liabilities | 1,738,150 | 1,746,656 | 859,172 | 757,397 |
| Total liabilities | 1,738,150 | 1,746,656 | 859,172 | 757,397 |
| Total equity | 83,448 | 138,368 | 246,748 | 286,470 |
| Equity attributable to owners | 73,894 | 123,284 | 231,547 | 271,610 |
| Interest-bearing borrowings | 748,000 | 918,500 | 341,800 | 213,400 |
Cash Flow Statement
| Item | 2013 | 2014 | 2015 | 2016-04 |
|---|---|---|---|---|
| Net cash from operating activities | 213,634 | 205,951 | 198,902 | 58,801 |
| Net cash from investing activities | -379,279 | -118,752 | 872,760 | 56,377 |
| Net cash from financing activities | 179,118 | -95,792 | -1,013,488 | -142,649 |
| Net increase in cash | 13,473 | -8,593 | 58,174 | -27,471 |
| Depreciation of PP&E | 39,988 | 37,646 | 38,952 | 13,659 |
| Purchase of PP&E | -34,601 | -18,156 | -86,036 | -14,717 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 10.6 |
|---|---|
| First Day Open | HK$ 11.5 |
| First Day Change | -8.62% |
| First Day Volume | 11178400.0 |
| First Day Turnover | 120905000.0 |
| Use of Proceeds | 1、約90.4百萬港元 (或所得款項凈額9%)將用于擴大及增加康華醫院及仁康醫院現有的醫療保健服務;
2、約361.6百萬港元(或所得款項凈額36%)將用于擴大我們在多學科專業治療及診斷方面的營運能力以及多學科專業治療及診斷的能力以及升級康華醫院及仁康醫院的醫療設施;
3、約100.5百萬港元(或所得款項凈額10%)將用于與中國的第三方醫院擴展我們醫院的咨詢及管理業務;
4、約351.6百萬港元(或所得款項凈額35%)將用于擴展我們在中國的醫療保健業務,包括透過選擇性并購其他醫院;
5、約100.5百萬港元(或所得款項凈額10%)將撥作營運資金及作其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Overall Coordinators (1)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894
Joint Bookrunners (4)
Joint Lead Managers (5)
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | 升鹏有限公司 | 206,897,600 HKD | — | 5.34% | — | 6 months | 2017-05-08 |
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 王君揚 | — |
| Company Secretary | 黃偉囱、周慶齡 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 王君揚、王愛慈、陳旺枝及王愛勤為控股股東(一致行動人士),通過康華集團、興業集團及興達物業合共持有250,000,000股內資股,緊隨全球發售後約佔74.85%(假設超額配股權未獲行使)。 |
|---|




